Zoë is an experienced IP litigator with a strong technical background and has advised clients on IP disputes relating to a broad range of technological areas and industry sectors.

Zoë is particularly known for her expertise in advising clients in complex patent disputes, often with an international element, and recently, Zoë has acted for a range of clients, from telecoms/electronics/software companies to pharmaceutical and biotech companies. Zoë also advises on related issues arising from international technology standards, such as patent pools, licensing and FRAND, as well as regulatory issues and SPCs.

In addition to representing clients before the UK courts, Zoë has experience of European Patent Office opposition proceedings, and has represented clients in arbitration proceedings and mediations relating to technology contract disputes. Zoë has been involved in many multi-jurisdictional disputes, working with advisors from across Europe, North America, China, Korea and Japan, and, in many instances, has taken a role in coordinating such litigation. In 2003, Zoë spent six months in The Hague seconded to the IP/ICT department of a leading Dutch law firm.

Zoë has also been appointed by the UK court to supervise the execution of search and seizure orders by other firms.

Zoë frequently lectures on IP law, and is a tutor on the Oxford University Diploma in Intellectual Property Law and Practice. 

She is also a contributor to the CIPA Guide to the Patents Act.  In 2016, Zoë was invited to lecture on the Bristol University Law School Distinguished Alumni Lecture Series.

Zoë has been a partner at Powell Gilbert since its founding in 2007.

Key cases

  • Samsung Bioepis & Biogen v AbbVie (adalimumab)

  • ​Unwired Planet v Huawei & Others (telecommunications/FRAND licensing)

  • Good Technology v Airwatch (mobile management technology)

  • CompactGTL v Velocys (gas to liquid conversion)

  • Motorola Mobility v BT (digital TV)

  • Microsoft v Motorola Mobility (smartphones)

  • Mölnlycke v BSN Medical (wound dressings)

  • LG v Sony (blu-ray technology/FRAND licensing)

  • Apple v Nokia (smartphones)

  • Philips & Others v Alba (MPEG-2/FRAND licensing)

  • Dr Reddy’s v Eli Lilly (olanzapine)

  • Ivax v Chugai (nicorandil formulations)

  • Sony Computer Entertainment v Ball (copy protection circumvention devices)

  • Allergan v Pharmacia (latonoprost)

  • Affymetrix v Multilyte (DNA microarrays)

  • Oxford Gene Technology v Affymetrix (DNA microarrays)

  • Pharmacia v Merck (COX 2 inhibitors)

  • Iomega v Nomai (trade mark / passing off – ZIP disc technology)